nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—PTGFR—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00706	0.248	CbGpPWpGaD
Carboprost Tromethamine—Hiccups—Doxorubicin—peripheral nervous system neoplasm	0.0018	0.00186	CcSEcCtD
Carboprost Tromethamine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00179	0.00185	CcSEcCtD
Carboprost Tromethamine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00179	0.00185	CcSEcCtD
Carboprost Tromethamine—Cramps of lower extremities—Epirubicin—peripheral nervous system neoplasm	0.00179	0.00184	CcSEcCtD
Carboprost Tromethamine—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.00179	0.00184	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.00178	0.00183	CcSEcCtD
Carboprost Tromethamine—Pain—Melphalan—peripheral nervous system neoplasm	0.00177	0.00182	CcSEcCtD
Carboprost Tromethamine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00177	0.00182	CcSEcCtD
Carboprost Tromethamine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.0018	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.00174	0.00179	CcSEcCtD
Carboprost Tromethamine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00172	0.00177	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00171	0.00176	CcSEcCtD
Carboprost Tromethamine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.0017	0.00175	CcSEcCtD
Carboprost Tromethamine—Cough—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.00175	CcSEcCtD
Carboprost Tromethamine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00169	0.00174	CcSEcCtD
Carboprost Tromethamine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.00173	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00167	0.00172	CcSEcCtD
Carboprost Tromethamine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.00166	0.00171	CcSEcCtD
Carboprost Tromethamine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00166	0.00171	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00166	0.00171	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00166	0.00171	CcSEcCtD
Carboprost Tromethamine—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.00166	0.00171	CcSEcCtD
Carboprost Tromethamine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00165	0.0017	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00169	CcSEcCtD
Carboprost Tromethamine—Flushing—Etoposide—peripheral nervous system neoplasm	0.00162	0.00167	CcSEcCtD
Carboprost Tromethamine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00162	0.00167	CcSEcCtD
Carboprost Tromethamine—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.00161	0.00165	CcSEcCtD
Carboprost Tromethamine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.0016	0.00164	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.0016	0.00164	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00159	0.00164	CcSEcCtD
Carboprost Tromethamine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00158	0.00163	CcSEcCtD
Carboprost Tromethamine—Eye pain—Epirubicin—peripheral nervous system neoplasm	0.00157	0.00161	CcSEcCtD
Carboprost Tromethamine—Chills—Etoposide—peripheral nervous system neoplasm	0.00157	0.00161	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00161	CcSEcCtD
Carboprost Tromethamine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00156	0.00161	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00156	0.00161	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00156	0.0016	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.0016	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00155	0.00159	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00155	0.00159	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00158	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00153	0.00158	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00153	0.00157	CcSEcCtD
Carboprost Tromethamine—Infection—Vincristine—peripheral nervous system neoplasm	0.00152	0.00157	CcSEcCtD
Carboprost Tromethamine—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00156	CcSEcCtD
Carboprost Tromethamine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00152	0.00156	CcSEcCtD
Carboprost Tromethamine—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.00151	0.00156	CcSEcCtD
Carboprost Tromethamine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00151	0.00155	CcSEcCtD
Carboprost Tromethamine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00151	0.00155	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.0015	0.00154	CcSEcCtD
Carboprost Tromethamine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00149	0.00153	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00148	0.00152	CcSEcCtD
Carboprost Tromethamine—Back pain—Etoposide—peripheral nervous system neoplasm	0.00147	0.00151	CcSEcCtD
Carboprost Tromethamine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00147	0.00151	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00146	0.00151	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00146	0.0015	CcSEcCtD
Carboprost Tromethamine—Eye pain—Doxorubicin—peripheral nervous system neoplasm	0.00145	0.00149	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00149	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00145	0.00149	CcSEcCtD
Carboprost Tromethamine—Lethargy—Epirubicin—peripheral nervous system neoplasm	0.00144	0.00149	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00144	0.00148	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00144	0.00148	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00147	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00142	0.00146	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00142	0.00146	CcSEcCtD
Carboprost Tromethamine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00145	CcSEcCtD
Carboprost Tromethamine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.00141	0.00145	CcSEcCtD
Carboprost Tromethamine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00141	0.00145	CcSEcCtD
Carboprost Tromethamine—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.0014	0.00144	CcSEcCtD
Carboprost Tromethamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0014	0.00144	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.0014	0.00144	CcSEcCtD
Carboprost Tromethamine—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00139	0.00143	CcSEcCtD
Carboprost Tromethamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00139	0.00143	CcSEcCtD
Carboprost Tromethamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00139	0.00143	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00138	0.00142	CcSEcCtD
Carboprost Tromethamine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00137	0.00141	CcSEcCtD
Carboprost Tromethamine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00136	0.0014	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.0014	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00139	CcSEcCtD
Carboprost Tromethamine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00139	CcSEcCtD
Carboprost Tromethamine—Infection—Cisplatin—peripheral nervous system neoplasm	0.00135	0.00139	CcSEcCtD
Carboprost Tromethamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00134	0.00138	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00134	0.00138	CcSEcCtD
Carboprost Tromethamine—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.00134	0.00138	CcSEcCtD
Carboprost Tromethamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00133	0.00137	CcSEcCtD
Carboprost Tromethamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.00137	CcSEcCtD
Carboprost Tromethamine—Rash—Topotecan—peripheral nervous system neoplasm	0.00133	0.00137	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00133	0.00137	CcSEcCtD
Carboprost Tromethamine—Cough—Etoposide—peripheral nervous system neoplasm	0.00133	0.00137	CcSEcCtD
Carboprost Tromethamine—Headache—Topotecan—peripheral nervous system neoplasm	0.00132	0.00136	CcSEcCtD
Carboprost Tromethamine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.00136	CcSEcCtD
Carboprost Tromethamine—Rash—Tretinoin—peripheral nervous system neoplasm	0.00132	0.00136	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00132	0.00136	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00132	0.00136	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00132	0.00136	CcSEcCtD
Carboprost Tromethamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00132	0.00136	CcSEcCtD
Carboprost Tromethamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00135	CcSEcCtD
Carboprost Tromethamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00135	CcSEcCtD
Carboprost Tromethamine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00131	0.00135	CcSEcCtD
Carboprost Tromethamine—Pain—Vincristine—peripheral nervous system neoplasm	0.00131	0.00135	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00131	0.00135	CcSEcCtD
Carboprost Tromethamine—Rash—Melphalan—peripheral nervous system neoplasm	0.00131	0.00134	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.0013	0.00134	CcSEcCtD
Carboprost Tromethamine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00129	0.00133	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00133	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00126	0.0013	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00129	CcSEcCtD
Carboprost Tromethamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.00126	0.00129	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00125	0.0439	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00125	0.00128	CcSEcCtD
Carboprost Tromethamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00125	0.00128	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00124	0.00128	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00127	CcSEcCtD
Carboprost Tromethamine—Infection—Etoposide—peripheral nervous system neoplasm	0.00123	0.00127	CcSEcCtD
Carboprost Tromethamine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00123	0.00127	CcSEcCtD
Carboprost Tromethamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.00123	0.00127	CcSEcCtD
Carboprost Tromethamine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00122	0.00126	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00122	0.0429	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00125	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00121	0.00125	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00121	0.00125	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00121	0.00124	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.0012	0.00123	CcSEcCtD
Carboprost Tromethamine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.0012	0.00123	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00117	0.00121	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00117	0.00121	CcSEcCtD
Carboprost Tromethamine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00116	0.00119	CcSEcCtD
Carboprost Tromethamine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00117	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00117	CcSEcCtD
Carboprost Tromethamine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00113	0.00117	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00113	0.00116	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00112	0.0392	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00111	0.00115	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00111	0.00114	CcSEcCtD
Carboprost Tromethamine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.0011	0.00114	CcSEcCtD
Carboprost Tromethamine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0011	0.00113	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00109	0.0384	CbGpPWpGaD
Carboprost Tromethamine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00112	CcSEcCtD
Carboprost Tromethamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00112	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00109	0.00112	CcSEcCtD
Carboprost Tromethamine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00108	0.00111	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00107	0.0011	CcSEcCtD
Carboprost Tromethamine—Pain—Etoposide—peripheral nervous system neoplasm	0.00106	0.00109	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00109	CcSEcCtD
Carboprost Tromethamine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00108	CcSEcCtD
Carboprost Tromethamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00105	0.00108	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00105	0.00108	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00106	CcSEcCtD
Carboprost Tromethamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00102	0.00105	CcSEcCtD
Carboprost Tromethamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00101	0.00104	CcSEcCtD
Carboprost Tromethamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00104	CcSEcCtD
Carboprost Tromethamine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00104	CcSEcCtD
Carboprost Tromethamine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00103	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.001	0.00103	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000998	0.00103	CcSEcCtD
Carboprost Tromethamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000996	0.00103	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000981	0.00101	CcSEcCtD
Carboprost Tromethamine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000981	0.00101	CcSEcCtD
Carboprost Tromethamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000974	0.001	CcSEcCtD
Carboprost Tromethamine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000972	0.001	CcSEcCtD
Carboprost Tromethamine—Rash—Vincristine—peripheral nervous system neoplasm	0.000966	0.000994	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000965	0.000993	CcSEcCtD
Carboprost Tromethamine—Headache—Vincristine—peripheral nervous system neoplasm	0.00096	0.000988	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000952	0.00098	CcSEcCtD
Carboprost Tromethamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000944	0.000972	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000927	0.000954	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000914	0.000941	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000913	0.00094	CcSEcCtD
Carboprost Tromethamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.00091	0.000937	CcSEcCtD
Carboprost Tromethamine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000909	0.000935	CcSEcCtD
Carboprost Tromethamine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.00089	0.000917	CcSEcCtD
Carboprost Tromethamine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000879	0.000904	CcSEcCtD
Carboprost Tromethamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000861	0.000887	CcSEcCtD
Carboprost Tromethamine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000854	0.000879	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000853	0.000878	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000849	0.000874	CcSEcCtD
Carboprost Tromethamine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000845	0.00087	CcSEcCtD
Carboprost Tromethamine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000841	0.000866	CcSEcCtD
Carboprost Tromethamine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000836	0.000861	CcSEcCtD
Carboprost Tromethamine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000828	0.000852	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000827	0.029	CbGpPWpGaD
Carboprost Tromethamine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000825	0.000849	CcSEcCtD
Carboprost Tromethamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000821	0.000845	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.00082	0.000844	CcSEcCtD
Carboprost Tromethamine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000813	0.000837	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00081	0.0284	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000805	0.000828	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000803	0.000827	CcSEcCtD
Carboprost Tromethamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000789	0.000812	CcSEcCtD
Carboprost Tromethamine—Rash—Etoposide—peripheral nervous system neoplasm	0.000783	0.000805	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000782	0.000805	CcSEcCtD
Carboprost Tromethamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000777	0.0008	CcSEcCtD
Carboprost Tromethamine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000774	0.000797	CcSEcCtD
Carboprost Tromethamine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000766	0.000788	CcSEcCtD
Carboprost Tromethamine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000766	0.000788	CcSEcCtD
Carboprost Tromethamine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000764	0.000787	CcSEcCtD
Carboprost Tromethamine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000763	0.000785	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000758	0.000781	CcSEcCtD
Carboprost Tromethamine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000753	0.000775	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000749	0.000771	CcSEcCtD
Carboprost Tromethamine—Cough—Epirubicin—peripheral nervous system neoplasm	0.000744	0.000766	CcSEcCtD
Carboprost Tromethamine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000743	0.000765	CcSEcCtD
Carboprost Tromethamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000737	0.000759	CcSEcCtD
Carboprost Tromethamine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000736	0.000757	CcSEcCtD
Carboprost Tromethamine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000726	0.000747	CcSEcCtD
Carboprost Tromethamine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000726	0.000747	CcSEcCtD
Carboprost Tromethamine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000723	0.000744	CcSEcCtD
Carboprost Tromethamine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000709	0.000729	CcSEcCtD
Carboprost Tromethamine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000707	0.000728	CcSEcCtD
Carboprost Tromethamine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000697	0.000717	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000696	0.000716	CcSEcCtD
Carboprost Tromethamine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000693	0.000714	CcSEcCtD
Carboprost Tromethamine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000691	0.000711	CcSEcCtD
Carboprost Tromethamine—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000688	0.000708	CcSEcCtD
Carboprost Tromethamine—Shock—Epirubicin—peripheral nervous system neoplasm	0.000684	0.000704	CcSEcCtD
Carboprost Tromethamine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000681	0.000701	CcSEcCtD
Carboprost Tromethamine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000679	0.000699	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000673	0.000692	CcSEcCtD
Carboprost Tromethamine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000671	0.000691	CcSEcCtD
Carboprost Tromethamine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000671	0.000691	CcSEcCtD
Carboprost Tromethamine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000669	0.000689	CcSEcCtD
Carboprost Tromethamine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000644	0.000663	CcSEcCtD
Carboprost Tromethamine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000639	0.000658	CcSEcCtD
Carboprost Tromethamine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000634	0.000652	CcSEcCtD
Carboprost Tromethamine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000633	0.000652	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00063	0.0221	CbGpPWpGaD
Carboprost Tromethamine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.000647	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000625	0.000643	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.000641	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.00062	0.000638	CcSEcCtD
Carboprost Tromethamine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000618	0.000637	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000617	0.0216	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000604	0.0212	CbGpPWpGaD
Carboprost Tromethamine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000595	0.000612	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000591	0.0208	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000586	0.000604	CcSEcCtD
Carboprost Tromethamine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.000595	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.000591	CcSEcCtD
Carboprost Tromethamine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000572	0.000589	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000561	0.0197	CbGpPWpGaD
Carboprost Tromethamine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00055	0.000567	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00055	0.000566	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.000549	0.0193	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000513	0.000528	CcSEcCtD
Carboprost Tromethamine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000509	0.000524	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000502	0.0176	CbGpPWpGaD
Carboprost Tromethamine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000514	CcSEcCtD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.000491	0.0172	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000476	0.00049	CcSEcCtD
Carboprost Tromethamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000474	0.000488	CcSEcCtD
Carboprost Tromethamine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000475	CcSEcCtD
Carboprost Tromethamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00046	0.000474	CcSEcCtD
Carboprost Tromethamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000455	CcSEcCtD
Carboprost Tromethamine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.000453	CcSEcCtD
Carboprost Tromethamine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000439	0.000451	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000451	CcSEcCtD
Carboprost Tromethamine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000449	CcSEcCtD
Carboprost Tromethamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.000438	CcSEcCtD
Carboprost Tromethamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000413	0.000425	CcSEcCtD
Carboprost Tromethamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000421	CcSEcCtD
Carboprost Tromethamine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000406	0.000418	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000417	CcSEcCtD
Carboprost Tromethamine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000415	CcSEcCtD
Carboprost Tromethamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000382	0.000394	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000372	0.013	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000364	0.0128	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000356	0.0125	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000348	0.0122	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000323	0.0113	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000316	0.0111	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00031	0.0109	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000305	0.0107	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000303	0.0107	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.000299	0.0105	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000283	0.00994	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000277	0.00973	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00027	0.00947	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000264	0.00927	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000247	0.00869	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000245	0.0086	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000242	0.00851	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00024	0.00842	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000226	0.00794	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000221	0.00777	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000191	0.0067	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000187	0.00656	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000183	0.00644	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000183	0.00643	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.00018	0.0063	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000179	0.00629	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00016	0.00562	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000157	0.0055	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000145	0.0051	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000145	0.00508	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000142	0.00499	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000142	0.00497	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00014	0.00491	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000137	0.00481	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000134	0.00471	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000134	0.00469	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000131	0.00461	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000131	0.00459	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000127	0.00446	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000124	0.00436	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.0001	0.00352	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.82e-05	0.00345	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.83e-05	0.0031	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.64e-05	0.00303	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.58e-05	0.00301	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	8.4e-05	0.00295	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8.18e-05	0.00287	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	8e-05	0.00281	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.5e-05	0.00263	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	7.34e-05	0.00258	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.31e-05	0.00186	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.21e-05	0.00183	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.19e-05	0.00182	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.1e-05	0.00179	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.12e-05	0.00145	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.03e-05	0.00142	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.88e-05	0.00136	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.8e-05	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.77e-05	0.00133	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.74e-05	0.00131	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.7e-05	0.0013	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.66e-05	0.00129	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.43e-05	0.0012	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.36e-05	0.00118	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.13e-05	0.0011	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.07e-05	0.00108	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.92e-05	0.00103	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.86e-05	0.001	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.4e-05	0.000842	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.35e-05	0.000824	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.29e-05	0.000805	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.24e-05	0.000788	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.03e-05	0.000711	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.98e-05	0.000696	CbGpPWpGaD
